10X GENOMICS INC-CLASS A (TXG) Stock Income Statement
NASDAQ:TXG - Nasdaq - US88025U1097 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 624.66M | 610.78M | 618.73M | 516.40M | 490.50M | |||
| Cost Of Goods | 197.65M | 196.00M | 209.41M | 120.40M | 74.10M | |||
| Gross Profit | 427.01M | 414.78M | 409.31M | 396.00M | 416.40M | |||
| Operating Expenses | 608.60M | 607.24M | 604.26M | 564.00M | 468.60M | |||
| Research and Development | 260.31M | 264.00M | 268.23M | 265.70M | 211.80M | |||
| Selling, General, and Administrative Expenses | 348.30M | 343.24M | 336.03M | 298.30M | 257.60M | |||
| Operating Income | -181.59M | -192.46M | -194.95M | -167.90M | -52.30M | |||
| Interest Income/Expense | 17.39M | 18.44M | 15.17M | 6.20M | -700.00K | |||
| Other Income/Expense | 1.59M | -1.58M | 1.39M | -200.00K | -800.00K | |||
| Non Recurring Items | N/A | -2.10M | -70.38M | 0.00 | 0.00 | |||
| Income Before Taxes | -153.40M | -177.70M | -248.76M | -162.00M | -53.70M | |||
| Income Tax | 3.63M | 4.93M | 6.34M | 4.00M | 4.50M | |||
| Net Income | -157.04M | -182.63M | -255.10M | -166.00M | -58.20M | |||
| EBITDA | -146.88M | -156.58M | -159.44M | -142.53M | -31.18M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.30 | -1.52 | -2.18 | -1.46 | -0.53 | |||
| Non GAAP EPS | -1.38 | -1.52 | -2.17 | -1.47 | -0.52 | |||
| Statistics | ||||||||
| Gross Profit Margin | 68.36% | 67.91% | 66.15% | 76.68% | 84.89% | |||
| Profit Margin | -25.14% | -29.90% | -41.23% | -32.15% | -11.87% | |||
| Operating Profit Margin | -29.07% | -31.51% | -31.51% | -32.51% | -10.66% | |||
All data in USD